Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Resmed (RSMDF) Asset Writedowns and Impairment (2017 - 2020)

Historic Asset Writedowns and Impairment for Resmed (RSMDF) over the last 9 years, with Q1 2020 value amounting to $9.1 million.

  • Resmed's Asset Writedowns and Impairment rose 5576.86% to $9.1 million in Q1 2020 from the same period last year, while for Mar 2020 it was $20.7 million, marking a year-over-year increase of 2355.43%. This contributed to the annual value of $15.0 million for FY2019, which is 2944.88% up from last year.
  • Per Resmed's latest filing, its Asset Writedowns and Impairment stood at $9.1 million for Q1 2020, which was up 5576.86% from $2.8 million recorded in Q4 2019.
  • Resmed's 5-year Asset Writedowns and Impairment high stood at $9.1 million for Q1 2020, and its period low was $382000.0 during Q1 2017.
  • In the last 4 years, Resmed's Asset Writedowns and Impairment had a median value of $1.7 million in 2018 and averaged $3.3 million.
  • Per our database at Business Quant, Resmed's Asset Writedowns and Impairment skyrocketed by 48324.8% in 2018 and then crashed by 2216.23% in 2019.
  • Resmed's Asset Writedowns and Impairment (Quarter) stood at $1.3 million in 2017, then fell by 3.41% to $1.2 million in 2018, then surged by 126.68% to $2.8 million in 2019, then soared by 221.67% to $9.1 million in 2020.
  • Its last three reported values are $9.1 million in Q1 2020, $2.8 million for Q4 2019, and $2.6 million during Q3 2019.